U.K. switches nicotinamide
This article was originally published in The Tan Sheet
Executive Summary
The U.K. health authority approves switching Freederm Gel PL (nicotinamide) acne treatment to OTC. The Medicines and Healthcare products Regulatory Agency Feb. 19 says it reclassified nicotinamide 4 percent topical gel from pharmacy status, similar to nonprescription behind-the-counter in the U.S., to general sale for the treatment of mild to moderate inflammatory acne vulgaris. The change follows Diomed Developments' filing of a switch application (1"The Tan Sheet" Oct, 13, 2008, In Brief)